chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got COVID a couple days ago/ When I tested positive on Tuesday; I got COVID a couple days ago/ When I tested positive on Tuesday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "I got COVID a couple days ago/ When I tested positive on Tuesday". The patient underwent the following laboratory tests and procedures: Body temperature: 101; SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Caller mentioned that he already took the 5 doses of Pfizer covid 19 vaccine and now he was taking Paxlovid pill. Caller asked if the anti-bodies were still on his body. Caller stated, he got COVID a couple days ago. The symptoms were mild. He was exposed on Saturday through Sunday. He got it from his girlfriend. She came down with symptoms on Sunday. He came down with symptoms on Tuesday, which was 3 days after his first exposure. When he tested positive on Tuesday, his doctor prescribed Paxlovid. That evening he had a fever 101. He woke up Wednesday, morning but the fever was gone, no runny nose, no sore throat. Since he took Paxlovid early on in the cycle, he was trying to find out did the antibodies short circuit. Asked if the antibodies stop the antiviral process or not. The antiviral might have screwed up his antibody production. Caller asked how he will know how long to wait to receive his next booster dose. He asked should he do his COVID infection as his start date or does he use the date of his last vaccine dose.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
p/vax pt exp lt arm swelling; redness; pain & chills; also noted axilla lymph nodes swelling;
Information has been received from a physician concerning a 50 year old male who on 12/06/99 was vaccinated with a 1st dose of Hepatitis B vaccine recombinant. On 12/07/99, the patient experienced respiratory symptoms, fever, headache, and cough. He recovered after one week. He was vaccinated with the 2nd dose of Hepatitis B vaccine recombinant on 01/06/00. He experienced respiratory symptoms, fever, headache and cough again, this time much worse than the first. The patient's symptoms persisted at the time of the report, five days after onset. It was also noted he received a flu shot in October 1999. No further information is available.
Arm is hurting across.; Headache; Right side of my chest really hurts.; Hard to breathe.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 51-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date was not reported), via an unspecified route of administration on 10Sep2021 (Age at vaccination was 51 years) as dose 2, single for covid-19 immunization. The patient medical history was not reported. The patient did not have any other medical condition. There were no concomitant medications. The patient did not receive any other vaccine. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration, on 20Aug2021 as dose 1, single for COVID-19 immunization. On 11Sep2021 patient was stated that he gets his second shot last night. Today, patient woke up, his arm was hurting across and headache, but his right side of his chest really hurts. It's kind of, hard to breathe and his chest hurts really bad on that side, Not his heart side. The right side where, he got the shot. Patient went to the pharmacist and she doesn't know. Patient got a little worse, since this morning but not much but he can tell it's still strong. So, If it doesn't go away then quick here he will go to the hospital cause there's something wrong. The patient did not perform any lab test. The patient did not receive any treatment for the events. The outcome of all the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This 25  year old white  female received the Covid shot on 1/26/21 and went to the ED on  2/26/21 with the following diagnoses listed below.  The patient was under the care of an OB/GYN.  It is unknown if this patient was pregnant and would need further investigation. N93.9 - Abnormal uterine and vaginal bleeding, unspecified.
WHILE WAITING THE 15 MINUTES AFTER VACCINATION CLIENT EXPERIENCED RASH STARTING AT NECK AND THEN PROGRESSING ALL OVER HER BODY. STATES FELT ITCHY. NOTIFIED PARKING ATTENDANT. EMT SUMMONED. DENIED BREATHING DIFFICULTIES. EMT GAVE OXYGEN AND BENADRYL. FAMILY MEMBER CAME TO PICK UP CLIENT AND GIVE RIDE HOME.
A NP reported that a 25 month old female received her 1st dose of Prevnar on 10/9/00 and 2 day later, developed erythema with a warm and tender area at the injection site along with "secondary cellulitis". The pt was seen in the office that day and was prescribed cephalexin hydrochloride and warm compresses. The pt recovered.
3/30/23  I woke up with tightness in my chest indicating an asthma episode. I took my inhalers and it subsided. The next day it was a tiny bit worse. I went to Urgent Care 4/1/23. I was diagnosed with Bronchitis.  I was prescribed Albuterol, Prednisone and an antibiotic.  I was pretty sick for about seven or eight days. I had to have a second round of  antibiotic and a small course of Prednisone. In about another week, things began to clear up.  I am on cough medicine. I have been off the nebulizer for about two weeks.
First I saw spots and then zig- zag lines across the tv-like a visual migraine-this lasted about 10 minutes. During that time I could not comprehend what I was reading on my phone. Shortly after I got a phone call and I could not pronounce three or four words  no matter how hard I tried to form those words. Then I was OK. The whole incident lasted around thirty minutes.
Red rash and itching at injection site - started small and then spread to whole upper area of arm. Began 1 week after injection and lasted for 3 days
- Here ER F/U for Hives 1/23. - He got 6 month shots _ Pediarix, Prev, Hib Rota - with Synagis on 1/22. - He received Synagis 11/27 and 12/24 with Rota with no reaction.
she is beyond the recommended dosing interval; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (she is beyond the recommended dosing interval) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (she is beyond the recommended dosing interval). On 28-Mar-2021, PRODUCT DOSE OMISSION ISSUE (she is beyond the recommended dosing interval) had resolved.            No concomitant medication use was provided by the reporter.  Husband of patient reported that he and his wife did not have any adverse events with the two shots.   No treatment of events was reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: ADR form was received with updated reporter address and Dose 2 information,; Reporter's Comments: This report refers to a case of Missed dose, for mRNA-1273, lot #: 012M20A,  with no associated AEs.
Per report from patient's husband, the patient developed a fever to 103 on the evening of 6/21/21. She awoke in the morning and was "not herself". He describes her as having difficulty breathing and not being lucid. He took her to the hospital where she was  hospitalized and then he got a call from the hospital in the evening reporting that she had walked to the restroom and then collapsed. Per his report, she had CPR performed for 30 minutes prior to being declared deceased. His phone number is the one included in this report.
pt recvd vax approx 11-inc irritability starting 1 hr later cried constantly, dec appetite, did not nap; afebrile;
mild tenderness at the injection site; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "immunocompromised" (unspecified if ongoing), notes: being slightly immunocompromised. The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "mild tenderness at the injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
submassive PE and DVT with right heart strain, required ICU admission and anticoagulation.    Brother developed PE 2 weeks after pfizer vaccine as well.
soreness and irritation around the injection site; soreness and irritation around the injection site; Diarrhea; Vomiting; shortness of breath; Wheezing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for Covid-19 Immunization; Bnt162b2 (Dose:2), for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), VACCINATION SITE IRRITATION (non-serious), outcome "not recovered" and all described as "soreness and irritation around the injection site"; DIARRHOEA (non-serious), outcome "not recovered", described as "Diarrhea"; VOMITING (non-serious) with onset 07Jan2022, outcome "unknown", described as "Vomiting"; DYSPNOEA (non-serious) with onset 07Jan2022, outcome "unknown", described as "shortness of breath"; WHEEZING (non-serious) with onset 07Jan2022, outcome "unknown", described as "Wheezing".  Additional Information: The Patient stated that she had the booster on Wednesday and since then she was experiencing soreness and irritation around the injection site. She was also experiencing diarrhea, today she experienced vomiting, shortness of breath, and wheezing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Obtained vaccinations on 1-30-13. Noticed large amount of bruising to right arm starting around injection site to shoulder. Bruising resolving currently.
Vaccine administration was tolerable with minor pain but around two hours after returning home her arm started to experience extreme pain. She is not able to lift her arm stating it feels like it has fallen out of socket.
Anaphylatic shock; Got Covid-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANAPHYLACTIC SHOCK (Anaphylatic shock) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Animal protein allergy.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANAPHYLACTIC SHOCK (Anaphylatic shock) (seriousness criterion medically significant) and COVID-19 (Got Covid-19). At the time of the report, ANAPHYLACTIC SHOCK (Anaphylatic shock) and COVID-19 (Got Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported. The treatment information was not provided.  A few people who had anaphylatic shock after getting the Covid-19 Vaccine got Covid.  Company Comment : Based on the current available information, the mRNA-1273 does not contain a virus capable of causing infection and with the occurrence of COVID-19 infection after vaccination, the causality of this event is assessed as not applicable. Regarding the event anaphylactic shock very limited information provided, however a causal relationship can not be excluded.; Sender's Comments: Based on the current available information, the mRNA-1273 does not contain a virus capable of causing infection and with the occurrence of COVID-19 infection after vaccination, the causality of this event is assessed as not applicable. Regarding the event anaphylactic shock very limited information provided, however a causal relationship can not be excluded.
low grade fever 100.2; mild fatigue/extreme fatigue; headache; not hungry; body felt heavy like someone was pushing down on them; sore arm; This is a spontaneous report from a contactable consumer. A 44-Year-old female patient received Pfizer Covid 19 (BNT162B2) (Batch/Lot number: EL9269, Expiration date: Unknown), on 12Feb2021 around 8.15Am on left Arm as Dose 2 single for covid 19 immunization (age at vaccination: 44-Year-old). Medical history included Blood pressure and heart burn. Concomitant medications were reported as unknown. Patient previously received first dose of BNT162B2 (Batch/Lot number: EL9261) around 3.30pm on left Arm as Dose 1 single for covid 19 immunization on 22Jan2021 and same day experienced mild fatigue and sore left arm at the injection site. Other medications in two weeks included blood pressure and heart burn medications. The patient had not affected with covid19 before or after vaccination. On 13Feb2021 patient experienced mild fatigue and sore arm (same day of the injection), the following day, low grade fever (100.2), extreme fatigue, headache, not hungry, body felt heavy like someone was pushing down on them and she woke up the next day and felt good. None of the Allergies were reported. No therapeutic treatments were received. The patient laboratorial test included fever 100.2 (low grade fever) on 13Feb2021. On an unspecified date in Feb2021 the outcome of the events was reported as recovered/resolved.  Follow-up attempts completed. No further information expected.
Headache; Fatigue; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 28Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 29Mar2021, outcome "unknown", described as "Headache"; FATIGUE (non-serious) with onset 29Mar2021, outcome "unknown", described as "Fatigue"; CHILLS (non-serious) with onset 29Mar2021, outcome "unknown", described as "Chills". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: she had the first dose of the Pfizer covid 19 vaccine on 28Mar2021 and her second dose is due 18Apr2021. Caller stated she will be out of town on 18Apr2021 and the 23rd through the 26th. Caller asked how long she can go before she can get her second dose and it will still be effective. Caller asked if she goes over the 6 weeks she does not need to go back to dose one. Caller reported that she will try to get the second dose 27Apr2021 -2May2021. Caller stated she had side effects the day after the first dose and reported to facility. It was reported that 28Mar2021 was her first dose of the covid vaccine. 29Mar2021 she had headache, fatigue, chills. 18Apr2021 is the second dose. She will be out of town, wondering how long she can go before receiving the second dose without losing efficacy of the vaccine.
Neck pain in the back of her neck; Terrible feeling.; She can't even drive in the car because her neck is so tight/, she can't turn to left, right; Is so severe it won't go away/pain gets more and more severe, she is still experiencing it/it was going up into the back of her head/pain is continuous/so severe it won't go away; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain in the back of her neck), FEELING ABNORMAL (Terrible feeling.), MOBILITY DECREASED (She can't even drive in the car because her neck is so tight/, she can't turn to left, right) and PAIN (Is so severe it won't go away/pain gets more and more severe, she is still experiencing it/it was going up into the back of her head/pain is continuous/so severe it won't go away) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 063E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck pain in the back of her neck), FEELING ABNORMAL (Terrible feeling.), MOBILITY DECREASED (She can't even drive in the car because her neck is so tight/, she can't turn to left, right) and PAIN (Is so severe it won't go away/pain gets more and more severe, she is still experiencing it/it was going up into the back of her head/pain is continuous/so severe it won't go away). At the time of the report, NECK PAIN (Neck pain in the back of her neck) and PAIN (Is so severe it won't go away/pain gets more and more severe, she is still experiencing it/it was going up into the back of her head/pain is continuous/so severe it won't go away) had not resolved and FEELING ABNORMAL (Terrible feeling.) and MOBILITY DECREASED (She can't even drive in the car because her neck is so tight/, she can't turn to left, right) outcome was unknown.            No concomitant medications reported.  No treatment information was reported by reporter.  Crossed linked-MOD21-136252, MOD21-136310, MOD21-136311
Seven days after my first dose of vaccine, the injection site became hard, red and itchy. The area grew to cover and and area of 5 inches by 4 in. Then blisters covered the area. Fifteen days after the injection, the area is covered with scabs and peeling.
a skin rash on my injection site one week after receiving the vaccine; Pain at the injection site; Raised, reddened, itchy area at injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PRURITUS (Raised, reddened, itchy area at injection site), VACCINATION SITE RASH (a skin rash on my injection site one week after receiving the vaccine) and INJECTION SITE PAIN (Pain at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Raised, reddened, itchy area at injection site). On an unknown date, the patient experienced VACCINATION SITE RASH (a skin rash on my injection site one week after receiving the vaccine) and INJECTION SITE PAIN (Pain at the injection site). On 01-Feb-2021, INJECTION SITE PRURITUS (Raised, reddened, itchy area at injection site) had resolved. At the time of the report, VACCINATION SITE RASH (a skin rash on my injection site one week after receiving the vaccine) and INJECTION SITE PAIN (Pain at the injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication included Air Shield Immunity Support Gummies 3 jan 2021. Treatment medication included hydrocortisone cream, Sarna lotion/ Camphor 0.5 %, Menthol 0.5% .   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Patient demographic details, second dose information, event start and stop date, outcome of event, concomitant medication were updated.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
On 6/16/00, went to ER; could not put any weight on my right knee. I was given medicine and a shot to ease the pain (ketorolac). Did not associate with Lymerix shot at this time. 60 day follow up states patient has slurred speech, memory lapses, mood swings and difficulty going up and down stairs. Per annual follow-up, doc #214882, patient is still receiving shots in knees, tried therapy, she does not believe it helped. She went to FLA for 2 months, she felt better there. She still has a lot of pain. The left knee is worse than the right one. The follow up received on 6/4/01 states, "5/24/01-no vaccine given unaware of any adverse events."
Systemic: Seizure-Mild, Additional Details: Patient sitting after vac. was administered. Patien was about to stand up but fainted  while on floor he had a seizure for about 3 secs. After the event he was alert & oriented, but did not remember the episode. BP #1 was 98/70 . Client was provided water and stayed in lying position for 40min with the supervision of the nurse. He wanted to drive himself to work but was told he should have someone pick him up however client refused stating his job was only \"5 min away\".BP before leaving 110/70.
Received Menactra in right arm and Tdap in left about 1 pm at school. Mom reports later that evening that student complains of sore arm- was given ibuprofen. Next day, patient came home from school early complaining of a very sore arm. Mom found right arm to warm to touch, solid red from just above elbow to just below shoulder (approx. 6 to 7 inches in width and length). On his left arm where he received the Tdap, patient also had redness, edema, and warm to touch at the site. However, the diameter was approx. ~3 inches. Mom had brought patient into Public Health to be evaluated. It was recommended to be seen at clinic. Patient was seen that very afternoon of May 7, 2014 with his personal MD. Dr. prescribed a 5 day course of prednisone. Mom noticed improvement in the next 24 to 36 hours of edema, redness, and soreness. When contacted on May 13, 2014, patient had completely recovered.
Patient was administered vaccine one month early (11/23/21 instead of 12/23/21). Pt has not yet reported experiencing any adverse event related to early administration.
litigation: MD states that pt is being sued in reference to a pt who allegedly recvd DTP immun n 1989; No further details or clinical info provided;